This revolutionary new ADHD treatment costs $1,000
For the first time, the Food and Drug Administration has approved a treatment for ADHD that isn't a drug. Instead, it's a medical device, known as Monarch eTNS, that works by stimulating the nervous system with an electric current.
Nervous stimulation at different parts of the body has been proven effective in treating conditions like depression and epilepsy, CBS New York explained. The device administers a mild "electrical shock" — in ADHD cases, to the nerves in the forehead — which is thought to help calm the part of the brain that causes the hyperactivity typical of people with ADHD.
This treatment is groundbreaking because ADHD treatment is tricky. While several drugs have proven effective, they often come with side effects. On the other hand, going without treatment can often lead to further mental health complications, such as "depression, chemical dependency, trouble learning in school, and trouble with the law," said Jeffrey Borenstein, the CEO of the Brain & Behavior Research Foundation.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
So non-drug treatments like this one are a major step in reducing the side effects and complications in people with ADHD. While it's still not entirely clear why electrical stimulation helps with hyperactivity, double-blind studies have found significant success, which is why the FDA approved the Monarch eTNS for treatment.
Further studies will need to be conducted to answer questions of how long the effects last, whether the Monarch eTNS can entirely replace ADHD drugs, and whether this will work with people of different ages. But for now, the device is available by prescription for about $1,000. Read more at CBS New York.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Shivani is the editorial assistant at TheWeek.com and has previously written for StreetEasy and Mic.com. A graduate of the physics and journalism departments at NYU, Shivani currently lives in Brooklyn and spends free time cooking, watching TV, and taking too many selfies.
-
The insides and outsides of Helsinki's energetic art scene
The Week Recommends Finland's capital has an admirable mix of street art and museums
By Catherine Garcia, The Week US Published
-
'We have witnessed firsthand how health and civics intersect'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Abortion rights are a 'core issue' for Kamala Harris
The Explainer She is featuring a 'rapid-response mentality' on reproductive rights
By Joel Mathis, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published